The Sherwin-Williams Company filings document operating results, governance actions, and capital-structure matters for an Ohio paint and coatings issuer with common stock listed on the New York Stock Exchange under SHW. Recent Form 8-K reports furnish quarterly and annual financial results, including net sales, earnings measures, segment performance, guidance, and Valspar acquisition-related amortization.
Proxy and annual-meeting filings cover director elections, advisory executive-compensation votes, auditor ratification, shareholder voting results, and pay-versus-performance disclosures. Other 8-K filings record material definitive agreements, amendments to credit facilities, borrowing and letter-of-credit commitments, covenants, events of default, and related direct financial obligations.
On November 4, 2026, James P. Lang, Sherwin-Williams’ SVP - Enterprise Finance & CAO, exercised options covering 620 shares at $295.83 and 689 shares at $193.35, then sold the corresponding shares. He sold 620 shares at a weighted average of $362.03 (trade prices ranged from $361.950 to $362.065) and 689 shares at $361.80. No Rule 10b5-1 plan is reported. A separate indirect holding lists 1,144.13 shares attributable to his participation in the 401(k) Plan per the trustee’s September 30, 2026 statement.
Sherwin-Williams (SHW) SVP - Corp Strategy & Devel. Bryan J. Young exercised 1,314 options on November 3, 2026, at a $127.98 per-share exercise price, acquiring 1,314 common shares and selling 1,314 shares that day at $345.71 per share. His reported employee stock option position after the exercise was 7,446 options. A separate indirect 401(k) Plan holding was 566.44 shares, per the trustee's September 30, 2026 statement. No Rule 10b5-1 plan is reported.
Sherwin-Williams SVP - IR & Corp. Comm. James R. Jaye exercised 4,527 employee stock options on November 3, 2026, at an exercise price of $134.63, acquiring 4,527 common shares. The reported option balance after the exercise was 0. He delivered or withheld 869 common shares for payment of exercise price or tax liability, recorded in two entries of 831 and 38 shares, and sold 2,301 shares at a weighted average price of $345.56. The sale prices ranged from $345.500 to $345.795. His indirect 401(k) Plan holding was 169.15 shares per the trustee's September 30, 2026 statement. The options were granted February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries, subject to vesting conditions.
Sherwin-Williams (SHW) reported that Mary L. Garceau, SVP - CLO and Secretary, sold 3,891 shares of common stock on November 2, 2026, at a weighted-average price of $350.4200 per share. After the sale, she directly held 31,466 shares. A separate 401(k) Plan entry reports 961.71 shares attributable to her participation, based on the trustee's September 30, 2026 statement. No Rule 10b5-1 plan is reported.
Sherwin Williams Co. officer James P. Lang gave notice of a proposed sale of 1,309 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $473,736.26 and an approximate sale date of November 4, 2026. The shares are listed as acquired from the issuer through a stock option exercise on November 4, 2026, for cash.
Sherwin Williams Co. (SHW) reports a proposed sale by Officer Bryan Young of 1,314 common shares, with an approximate sale date of November 3, 2026. The proposed sale has an aggregate market value of $454,268.46. Daniel Tucci signed as a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Bryan Young.
SHERWIN WILLIAMS CO (SHW) officer James R. Jaye reported a proposed sale of 2,301 common shares on November 3, 2026. The proposed sale is listed at an aggregate market value of $795,131.20, with Fidelity Brokerage Services LLC named as broker and NYSE as the exchange. The notice also reports a cash stock-option exercise from the issuer for 2,301 shares on November 3, 2026.
The Sherwin-Williams Company entered into Amendment No. 2 to its Amended and Restated Credit Agreement with Citicorp USA, Inc., as administrative agent and issuing bank, and the participating lenders. The amendment provides $75,000,000 of additional commitments available for borrowing and issuing letters of credit under the agreement. These additional commitments mature on December 20, 2031. The underlying credit agreement is dated November 17, 2025.
Sherwin-Williams Co. officer Mary L. Garceau’s notice lists a proposed sale of 3,891 common shares, with an aggregate market value of $1,363,502.49 and an approximate sale date of November 2, 2026. The securities history lists 650 shares acquired through restricted stock vesting on February 16, 2021, and 3,241 shares acquired through restricted stock vesting on February 17, 2026, each from the issuer as compensation.
The Sherwin-Williams Company (SHW) reported third-quarter 2026 net sales of $6.860 billion, up 7.9% year over year, while net income was $821.0 million versus $833.1 million. Diluted earnings per share were $3.38 versus $3.35. Gross margin was 47.8%, compared with 49.2%; the company cited mix, including Suvinil, and higher raw-material and supply-chain costs. Sales growth reflected higher sales across all three segments, price increases and the October 2025 Suvinil acquisition.
For the first nine months, net sales were $19.316 billion, up 7.4%, net income was $2.1993 billion versus $2.0917 billion, diluted EPS was $8.95 versus $8.34, and net operating cash was $2.591 billion versus $2.359 billion. The company repurchased 7,100,000 shares at an average $331.99 per share and paid $0.80 per share in dividends in each of the first three quarters. At September 30, 2026, cash and cash equivalents were $264.2 million, unused credit-agreement capacity was $2.322 billion and total debt outstanding was $11.7951 billion. A paint manufacturing business acquisition closed in June 2026 for approximately $75 million, subject to a contractual working capital adjustment.